Piper Brian
SEC insider (Form 3/4/5 filer). CIK 0001665924. EVP, Chief Financial Officer at Sana Biotechnology, Inc. (SANA). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 17, 2026. Located in SEATTLE, WA.
Companies Piper Brian has filed insider reports for
- Sana Biotechnology, Inc. (SANA): Officer, EVP, Chief Financial Officer
Piper Brian
CIK: 0001665924
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SANA
Sana Biotechnology, Inc.
Officer